First Neuropathic Drug to Prevent Post-chemotherapy Pain

A new molecule capable of preventing the development of peripheral neuropathy induced by chemotherapy in cancer patients, has been successfully tested by HUB-ICO-IDIBELL researchers of the Neuro-Oncology Unit of Bellvitge University Hospital - Catalan Institute of Oncology. The research spearheaded by Dr. Jordi Bruna has discovered that this drug has a completely novel mechanism of action and hence, would be the first treatment against this neurological complication.